Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Pfizer Inc To Split Generic, Branded Drugs Units-Reuters


Monday, 29 Jul 2013 01:46pm EDT 

Reuters reported that Pfizer Inc, in what could be the prelude to spinning off its generics drug business, said it plans to separate its commercial operations into two units, mainly for patent-protected brands and a third for generics. Pfizer, said on July 29, 2013 the changes will take effect by January in countries that do not require a consultation with labor unions. The business represents 17% of total sales and overwhelmingly comes from overseas. Baum and Fernandez said any spin-off of a company division would be unlikely before 2016, after Pfizer completes its examination. 

Company Quote

71.16
0.14 +0.20%
17 Apr 2014